Biotech Stocks Facing FDA Decision In May 2024 : vimarsana.c

As April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023.

Related Keywords

Canada , United States , Novo Nordisk , Bristol Myers Squibb , Novo Nordisk Awiqli , Genmab Tivdak , Ascendis Pharma , Pfizer Inc , Moderna Inc , Pfizer , European Union , Dynavax Technologies Corp , Smithkline Biological Arexvy , Toll Like Receptor , Myers Squibb , European Medicines Agency , Medicinal Products , Human Use ,